Clinical heterogeneity in monogenic chylomicronaemia

Publication date

2022-11-24

Authors

Heidemann, Britt E.
Bemelmans, Remy H.H.
Marais, A. David
Visseren, Frank L JISNI 0000000389493675
Koopal, Charlotte

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by_nc

Abstract

Chylomicronaemia accompanies hypertriglyceridaemia, usually due to a polygenic predisposition in combination with secondary risk factors. Monogenic chylomicronaemia represents a small subgroup of patients with hypertriglyceridaemia. This article describes three patients and illustrates the heterogeneity in the presentation of monogenic chylomicronaemia. The first case is a man with mild hypertriglyceridaemia who is a compound heterozygote for two variants in the LMF1 gene, without relevant medical history. The second case is a woman who is a double heterozygote of variants in the LPL and APOA5 genes. She experienced pancreatitis. The third case is a man, with recurrent pancreatitis attributed to severe hypertriglyceridaemia and homozygous for a variant in the APOC2 gene. This article highlights that in patients with hypertriglyceridaemia, the absence of pancreatitis or the presence of mild hypertriglyceridaemia does not exclude monogenic chylomicronaemia. Genetic screening should be considered in patients with unexplained or severe hypertriglyceridaemia, to determine appropriate treatment and follow-up.

Keywords

Genetics, Lipid disorders, Pancreatitis, General Medicine, Case Reports, Journal Article

Citation

Heidemann, B E, Bemelmans, R H H, Marais, A D, Visseren, F L J & Koopal, C 2022, 'Clinical heterogeneity in monogenic chylomicronaemia', BMJ Case Reports, vol. 15, no. 11, e251411, pp. 1-5. https://doi.org/10.1136/bcr-2022-251411